Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bausch + Lomb Corp.

13.73
-0.1600-1.15%
Post-market: 13.730.00000.00%16:42 EDT
Volume:530.96K
Turnover:7.26M
Market Cap:4.84B
PE:-15.24
High:13.79
Open:13.70
Low:13.53
Close:13.89
Loading ...

Company Profile

Company Name:
Bausch + Lomb Corp.
Exchange:
NYSE
Establishment Date:
1853
Employees:
13500
Office Location:
520 Applewood Crescent,Vaughan,Ontario,Canada
Zip Code:
L4K 4B4
Fax:
- -
Introduction:
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Directors

Name
Position
Joseph C. Papa
Chief Executive Officer and Chairman
Thomas W. Ross, Sr.
Lead Director
Andrew C. von Eschenbach
Director
John A. Paulson
Director
Nathalie Bernier
Director
Richard U. De Schutter
Director
Russel C. Robertson
Director
Sarah B. Kavanagh
Director

Shareholders

Name
Position
Joseph C. Papa
Chief Executive Officer and Chairman
Sam A. Eldessouky
Chief Financial Officer
Christina M. Ackermann
Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals
Joseph F. Gordon
President, Global Consumer, Surgical and Vision Care
Yehia Hashad
Executive Vice President of Research & Development and Chief Medical Officer